A daunting task: Manipulating leukocyte function with RNAi

Dan Peer*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

52 Scopus citations


RNA interference (RNAi) has advanced into clinical trials. In spite of the progress made in systemic RNAi delivery to the liver and solid tumors, delivery of RNAi to leukocytes remains challenging and less advanced. Manipulating leukocyte function with RNAi holds great promise for streamlining the drug discovery process by facilitating in vivo drug target validation and for facilitating the development of RNAi-based therapy platforms for leukocyte-implicated diseases, such as blood cancer, inflammation, and leukocyte-tropic viral infections. In this review, progress in delivery strategies of RNAi payloads to leukocytes, which are notoriously difficult cells to transduce with RNAi, is discussed with special emphasis on the challenges and potential opportunities for manipulating leukocyte function with RNAi.

Original languageEnglish
Pages (from-to)185-197
Number of pages13
JournalImmunological Reviews
Issue number1
StatePublished - May 2013


  • Integrins
  • Leukocytes
  • Liposomes
  • Nanoparticles
  • RNAi


Dive into the research topics of 'A daunting task: Manipulating leukocyte function with RNAi'. Together they form a unique fingerprint.

Cite this